BioLargo Inc (QX) (BLGO) Quote

$BLGO BioLargo Provides 2024 Review and 2025 Outlook

https://www.accesswire.com/968767/biolargo-provides-2024-review-and-2025-outlook

Continued Strong Revenue Growth; Zero Share Dilution in 2nd Half of 2024

WESTMINSTER, CA / ACCESSWIRE / January 15, 2025 / BioLargo, Inc. (OTCQX:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, is pleased to provide a recap of its successful 2024, and provide a corporate and business outlook for 2025.

"Thanks to the support of our shareholders, business partners, operating teams, and board, BioLargo had a widely successful 2024 spanning our business segments, financials, and stock performance. This past year was transformative for our company and was a testament to our evolution as a cleantech innovator and solutions provider. Our mission to create new cleantech technologies to solve tough problems advanced across all our operating segments," stated Dennis P. Calvert, President and CEO of BioLargo, Inc.

"Pooph, our consumer pet odor product line, is a great example of our core business model to invent a technology, prove it out, then partner with an expert that has the resources to properly monetize resulting products," continued Mr. Calvert. "Here, we partnered with award-winning consumer product experts to capitalize on our odor control technology. We receive a manufacturer's margin, royalty on sales, and 20% participation in any eventual sale of the brand. Pooph proved to be a significant contributor of revenue in 2024, having ramped to eight unique products, with more than fifteen SKUs available at retailers such as Amazon, Walmart, Target, The Home Depot, Petsmart, Chewy, PetCo and more."

Mr. Calvert continued, "Pooph was not our only success in 2024, as great strides were also made in our medical, equipment and energy divisions. In medical, our subsidiary Clyra Medical focused its efforts on preparation of its Bioclynse wound irrigation solution for launch for surgical applications, spending countless hours and more than $2 million readying the product for at-scale manufacturing at an FDA-compliant manufacturing partner."

"Our battery technology subsidiary completed its pilot manufacturing facility and successfully produced and tested prototype cells revalidating key data that came with the initial acquisition," stated Mr. Calvert. "Our liquid-sodium battery doesn't have the drawbacks of lithium cells - no runaway fires, no toxic or hard-to-source chemicals or minerals - and provides a better option for energy storage, empowering grid stability and storage of renewable energy. It's safer, more sustainable, more durable and more cost-efficient than other batteries. In 2025, we are working hard to scale up cells and battery packs, complete third-party validation testing, and secure manufacturing licensing partnerships around the world."

"Our innovative water treatment technologies made progress in 2024, securing the first commercial PFAS-treatment project, a project which we expect to be installed and running in early 2025. Our team at BioLargo Equipment Solutions & Technologies is highly encouraged by the pending completion of the first installation, and believes that project will springboard additional customers, which we hope will solidify our technology as a leader in economical, low-waste treatment of water contaminated with these ‘forever chemicals'", said Calvert.

He concluded by saying, "By maintaining a strong focus on financial responsibility and operational efficiency, we aim to maximize shareholder value while advancing our mission to drive innovation and expand our commercialization and product portfolio in 2025 and beyond."

2024 Corporate and Financial Review Highlights

Stock performance appreciation from $0.17 at the end of 2023 to a high of $0.45 in 2024, and currently at $0.30

Cash balance of $3.9 million at the end of the third quarter 2024; from $3.5 million at December 31, 2023

Shareholders' equity reached $6.0 million at the end of the third quarter 2024; from $4.2 million at December 31, 2023

Uplist from the OTCQB to the "OTCQX Best Market", the OTC Markets highest market level for established, investor-focused U.S. and international companies that meet high financial standards, follow best practice corporate governance, demonstrate compliance with U.S. securities laws and remain current in their disclosure

Less reliance on investor capital in the second half of 2024 due to increases in gross profits from operations, with no sales of common stock in the 2nd half of 2024

2025 Corporate Outlook

Having expanded the company's strong foundation and achieved impressive revenue growth in 2024, BioLargo is now looking ahead to broaden the commercial traction of its operating segments and products even further in 2025. Each of BioLargo's subsidiaries have potential to transform their respective markets and improve lives around the world. Based on the company's track record of growth and adoption in new business segments underway, management believes 2025 could shape up to be another record year.

BioLargo management has identified its key goals for the coming year:

Uplist to a national stock exchange such as NASDAQ or the NYSE

Grow top line revenues and continue historical revenue growth performance

Complete the years-long effort to launch the Bioclynse wound irrigation solution for use during surgery through an industry-leading distribution partner

For PFAS, complete system installation in New Jersey, collect data from its operations, and sell more treatment systems

For the battery company, complete development of the commercial-sized Cellinity battery cell and packs, validate performance claims through third-party experts, and secure partners for its franchise business model to build factories around the world

Support the expanding growth of the Pooph pet odor control product line

2024 in Review Highlights

Here the company has provided headlines and links to some of the key press releases from 2024:

BioLargo, Inc. CEO Dennis P. Calvert Appointed to U.S. Department of Commerce Environmental Technologies Trade Advisory Committee (ETTAC)

https://www.biolargo.com/post/biolargo-inc-ceo-dennis-p-calvert-appointed-to-u-s-department-of-commerce-environmental-technolo

BioLargo Validates Key Performance Metrics of Its Cellinity Battery Energy Storage Technology

https://www.biolargo.com/post/biolargo-validates-key-performance-metrics-of-its-cellinity-battery-energy-storage-technology

BioLargo Hosts Ribbon-Cutting Event for Battery Pilot Manufacturing Facility

https://www.biolargo.com/post/biolargo-to-host-ribbon-cutting-event-for-battery-pilot-manufacturing-facility

Clyra Medical Technologies, a Subsidiary of BioLargo, Appoints Dr. Steven J. Kavros as Chief Medical Officer

https://www.biolargo.com/post/clyra-medical-technologies-a-subsidiary-of-biolargo-appoints-dr-steven-j-kavros-as-chief-medical

BioLargo Engineering Increases Ongoing Revenue with Another Air Force Contract

https://biolargo.blogspot.com/2024/06/biolargo-engineering-increases-ongoing.html

BioLargo Subsidiary Clyra Medical Selects Keystone Industries to Support Manufacturing of its Medical Products

https://biolargo.blogspot.com/2024/06/biolargo-subsidiary-clyra-medical.html

BioLargo Manufactures First Cellinity Battery Cells, a Safer Alternative to Lithium-ion

https://biolargo.blogspot.com/2024/06/biolargo-manufactures-first-cellinity.html

BioLargo PFAS Removal Technology Meets New US Drinking Water Standards

https://biolargo.blogspot.com/2024/04/biolargo-pfas-removal-technology-meets.html

BioLargo Adds Larry Dick, Prominent Water Industry Veteran, to Board of Its Water Equipment Subsidiary

https://biolargo.blogspot.com/2024/02/biolargo-adds-larry-dick-prominent.html

BioLargo Recruits Sally Gutierrez, Former EPA Senior Advisor, for the Board of its Water Equipment and PFAS Solutions Company

https://biolargo.blogspot.com/2024/02/biolargo-recruits-sally-gutierrez.html

Jeffrey Kightlinger, Recognized Water Industry Leader, Joins Board of BioLargo's Water Equipment and PFAS Solutions Company

https://biolargo.blogspot.com/2024/02/jeffrey-kightlinger-recognized-water.html

BioLargo Launches Water Equipment Subsidiary to Capitalize on Opportunities in PFAS and Water Treatment

https://biolargo.blogspot.com/2024/01/biolargo-launches-water-equipment.html

Something's happening here, what it is isn't exactly clear!

$BLGO BioLargo, Inc. CEO Dennis P. Calvert Appointed to U.S. Department of Commerce Environmental Technologies Trade Advisory Committee (ETTAC)

https://www.accesswire.com/953750/biolargo-inc-ceo-dennis-p-calvert-appointed-to-us-department-of-commerce-environmental-technologies-trade-advisory-committee-ettac

WESTMINSTER, CA / ACCESSWIRE / December 12, 2024 / BioLargo, Inc. (OTCQX:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, announced that its President and CEO Dennis P. Calvert has been appointed by U.S. Secretary of Commerce Gina Raimondo to serve on the Environmental Technologies Trade Advisory Committee (ETTAC).

The ETTAC is a U.S. Department of Commerce committee that serves as an advisory body to the Environmental Trade Working Group (ETWG) of the Trade Promotion Coordinating Committee (TPCC), reporting through the Secretary of Commerce in her capacity as Chair of the TPCC, on trade policies and programs affecting the U.S. environmental technology industry, including programs to promote export of environmental technologies and services. ETTAC members are selected from industry-leading companies across sectors including water and wastewater treatment, air quality control, and solid waste management and recycling. Learn more at https://www.trade.gov/ettac.

On December 11, 2024, the Department of Commerce issued a press release announcing the ETTAC committee appointments for the 2024-2026 term: https://www.commerce.gov/news/press-releases/2024/12/us-secretary-commerce-appoints-new-advisors-environmental-technologies

"The U.S. environmental technologies sector represents $432 billion in revenue and employs 1.8 million American workers - making it a vital industry for driving innovation and positioning the United States as a global leader in environmental technologies," said Secretary Raimondo. "I look forward to receiving the committee's recommendations on approaches for how the Department can continue supporting the competitiveness of American environmental technologies."

Mr. Calvert, who will serve a two-year term on the ETTAC, commented, "I am honored to serve the Secretary of Commerce and advocate for programs that foster the expanded use of innovative technologies to safeguard the environment and human health."

He continued, "American innovators lead the world in the development of newer and better environmental technologies to address challenges such as sustainable water treatment targeting emerging contaminants like per- and polyfluoroalkyl substances (PFAS). Now is the time to promote the export of these technologies around the world to address these global issues."

Learn more about BioLargo's environmental technologies at www.biolargo.com.

$BLGO BioLargo Q3 2024 Earnings Results Webcast and Conference Call on Thursday, November 14, 2024 - 4:30 PM Eastern Time

https://www.accesswire.com/941977/biolargo-q3-2024-earnings-results-webcast-and-conference-call-on-thursday-november-14-2024-430-pm-eastern-time

WESTMINSTER, CA / ACCESSWIRE / November 13, 2024 / BioLargo, Inc. (OTCQX:BLGO), a developer of sustainable technologies and full-service environmental engineering company, announced it will host an investor webcast and conference call on Thursday, November 14, 2024 at 1:30 pm Pacific / 4:30 pm Eastern. The event, which will be open to the public, will be held to review the company's financial results for the three months and nine months ending September 30, 2024, discuss recent milestones, and conduct a question-and-answer session.

To listen to a live broadcast, go to the site linked below at least 15 minutes prior to the scheduled start time to register and download any necessary audio/video software.

To participate in the live webcast and teleconference:

Webcast Link: https://www.webcaster4.com/Webcast/Page/2448/51659
Teleconference Domestic: 888-999-6281
Teleconference International: +1-848-280-6550
Participant Access Code: BioLargo Inc.

To watch or listen to a replay of the webcast or teleconference:

Webcast Replay Expiration: Friday, February 14, 2025
Teleconference Replay Expiration: Thursday, November 28th, 2024
Teleconference Replay Domestic: 877-481-4010
Teleconference Replay International: 919-882-2331
Replay Passcode: 51659

The webcast replay and accompanying presentation materials will be made available on the Investor Relations section of BioLargo's website at www.biolargo.com/investor-relations.

$BLGO BioLargo Validates Key Performance Metrics of Its Cellinity Battery Energy Storage Technology

https://www.accesswire.com/930981/biolargo-validates-key-performance-metrics-of-its-cellinity-battery-energy-storage-technology

WESTMINSTER, CA / ACCESSWIRE / October 14, 2024 / BioLargo, Inc. (OTCQX:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, announced that its subsidiary BioLargo Energy Technologies, Inc. completed preliminary internal testing of its prototype battery cells confirming many of the technology's exceptional performance claims that make it an attractive battery technology for long duration energy storage.

The tests, done to verify the battery's performance claims made by its original inventors, confirmed the stability of the chemistry of the battery cell and the reliability of the component construction as a sealed, non-venting cell design with no self-discharging. The tests also helped verify the battery's ability to quickly charge and discharge at a high voltage.

Cellinity™ is BioLargo's next-generation battery platform designed to provide a better alternative to lithium-ion technology for applications including grid-scale storage, renewable energy storage, charging stations for electric vehicles, and a variety of other commercial and industrial applications. Cellinity is safer, more sustainable, longer lasting, and more energy-dense than lithium-ion batteries, traits that make it ideal for large-format long-duration energy storage applications. Learn more about Cellinity at www.BioLargoEnergy.com.

In addition to these internal tests, the company is also organizing third-party validation testing to be done on the more complex aspects of Cellinity's electrochemical performance with at least two acclaimed testing facilities.

Dennis P. Calvert, President and CEO of BioLargo, commented "With these results in hand, our engineers are now advancing the next steps in Cellinity's development: design and production of the larger format 'Spartan' Cellinity cells, and design and production of battery modules containing those cells. Stay tuned - we're very excited about the future of this important battery technology, and we think you should be too."

He continued, "According to a recently published article in The Economist titled 'Clean energy's next trillion-dollar business', global energy storage experts have predicted the global supply of battery energy storage will need to increase from today's 200 gigawatts to more than a terawatt by 2030 and more than five terawatts by 2050, fueling a market projected to be worth between $200 billion and $700 billion by 2030 and between $1 and $3 trillion by 2040. These projections underscore the critical role of batteries in the global energy transition and the massive global investment in battery innovation required to meet those targets. Because of its unique differentiators in safety, energy density, and lifespan, Cellinity is especially well-suited to assist in the global energy transition, and we intend to capitalize on that."

Undervalued and definitely total lack of investor awareness . . . Many catalysts that could SOON send shares soaring above record highs . . . Volume dead now. . . Now is time to load up!

$BLGO announced their breakthrough Cellinity Battery. Tomorrow’s battery is here today! The Cellinity #battery could be a gamechanger. https://richardacavalli.wixsite.com/greenplanetmicrocaps/gamechanger-cellinity-battery

Really big news that could send stars to $1.00 is imminent. Clyra . . . Pooph . . . Cellinity Battery . . . PFAS . . . earnings . . . Shares have been in a consolidation flag for 4 months after a huge move from 16 cents to 45 cents. Selling has died up and shares are poised for major move to $1.00. Buckle up!!!!!

$BLGO BioLargo Engineering Increases Ongoing Revenue with Another Air Force Contract


https://www.accesswire.com/879444/biolargo-engineering-increases-ongoing-revenue-with-another-air-force-contract

USAF work now amounts to over $100,000 in revenue per month.

WESTMINSTER, CA / ACCESSWIRE / June 20, 2024 / BioLargo, Inc. (OTCQX:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, announced that its engineering subsidiary has been awarded a subcontract to provide air quality services to two Arizona U.S. Air Force bases for up to four years, with expected annual revenue of approximately $812,000.

The news comes on the heels of a similar recently announced contract award to serve three Air Force bases in New Mexico, which has a potential annual average revenue of $650,000. BioLargo's work at the Arizona bases consists primarily of the air quality regulatory compliance portion of a Fence-to-Fence (F2F) support contract through prime contractor HLTLI Joint Venture, LLC, a joint venture between HL Environmental Services and TLI Solutions.

The four-year prime contract secures pricing for F2F services over the term of the contract but does not guarantee continuation of the contract over that duration. In the past, BioLargo's engineers have continued providing services through the duration of the prime contract. In total, BioLargo Engineering's work at Air Force bases now amounts to over $100,000 of revenue per month.

BioLargo Engineering, Science & Technologies President Randall Moore commented, "We are pleased and honored to continue providing vital engineering services to the United States Air Force and supporting their active mission and environmental compliance needs. These new contracts will provide for over $100,000 a month of ongoing fixed revenues while we continue to expand our abilities to support new opportunities."

$BLGO BioLargo Subsidiary Clyra Medical Selects Keystone Industries to Support Manufacturing of its Medical Products


https://www.accesswire.com/876410/biolargo-subsidiary-clyra-medical-selects-keystone-industries-to-support-manufacturing-of-its-medical-products

WESTMINSTER, CA / ACCESSWIRE / June 12, 2024 / BioLargo, Inc. (OTCQX:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, announced that its subsidiary Clyra Medical Technologies, Inc. ("Clyra") has selected Keystone Industries, a global manufacturer of medical, dental and cosmetic products with distribution partners in more than 70 countries, to support manufacturing of its medical products. The relationship focuses on the build-out of scaled manufacturing capacity for Clyra's FDA 510(k) cleared Bioclynse surgical wound irrigation solution. Clyra and Keystone have been and continue to make significant investments to support the launch of Bioclynse.

Bioclynse is Clyra's FDA 510(k) cleared, safe, highly effective, broad spectrum wound irrigation solution with enormous potential to improve patient outcomes in applications like orthopaedic surgery and dentistry. Advantages of Bioclynse include:

Non-cytotoxic, non-sensitizing, no damage to tissue
No rinse-out required
Non-staining
Sustained multi-day efficacy
Effective against biofilms
Cary Robinson, President and CEO of Keystone Industries, said, "We are excited to support Clyra Medical Technologies to bring Bioclynse to the market. Keystone has a century of experience in developing and manufacturing medical device, OTC and pharmaceutical products. We have committed a significant investment in our infrastructure to support the manufacturing of innovative products like Clyra's Bioclynse and can readily provide the needed support to scale up production rapidly."

Steve Harrison, President of Clyra Medical Technologies, commented, "We are continuing to work hard and spend money to support the scaled roll-out of the Bioclynse surgical wound irrigation solution. Finding a manufacturing partner willing to invest significant money in new equipment and dedicated space was critical to these efforts. We look forward to a long and mutually prosperous relationship with Keystone."

Good Morning $BLGO

Looking Great! $BLGO

Nice volume into the close and #HOD $BLGO

Cellinity is not a lithium-ion battery - rather, it uses a unique chemistry involving molten salt electrolytes that imparts substantial benefits over lithium-ion chemistry. $BLGO

Cellinity is BioLargo's next-generation battery platform designed to provide safe, environmentally conscious large-format long-duration battery energy storage for applications including grid-scale storage, renewable energy storage, charging stations for electric vehicles, and a variety of other commercial and industrial applications. $BLGO

BioLargo Inc. recently announced that it had succeeded in manufacturing its first CellinityTM "Liquid Sodium" prototype battery cells. Visit www.BioLargoEnergy.com to learn more.$BLGO

BioLargo, Inc.is a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges. $BLGO

Cellinity is BioLargo's next-generation battery platform designed to provide safe, environmentally conscious large-format long-duration battery energy storage for applications including grid-scale storage, renewable energy storage, charging stations for electric vehicles, and a variety of other commercial and industrial applications. Cellinity is not a lithium-ion battery - rather, it uses a unique chemistry involving molten salt electrolytes that imparts substantial benefits over lithium-ion chemistry. These newly manufactured Cellinity prototype cells will now be tested and validated for the energy storage and transfer performance claims that were generated in the technology's early-stage research and development by its original inventors:

Far greater safety - no runaway fires, no risk of explosion;
Extremely long-lasting - no performance decrease over thousands of cycles;
No self-discharging, no out-gassing, and no parasitic load for cooling;
High energy density - more energy per unit of weight than lithium batteries;
All materials can be sourced within North America without the need for rare-earth elements.

$BLGO Manufactures First Cellinity Battery Cells, a Safer Alternative to Lithium-ion
https://www.accesswire.com/875779/biolargo-manufactures-first-cellinity-battery-cells-a-safer-alternative-to-lithium-ion#:~:text=WESTMINSTER%2C%20CA%20%2F%20ACCESSWIRE%20%2F%20June,Liquid%20Sodium%22%20prototype%20battery%20cells.

$BLGO CEO reveals world-changing battery and new battery factories. CEO in interview says he expects news soon. Could send BLGO shares soaring.

$BLGO CEO reveals world-changing battery and new battery factories. CEO in interview says he expects news soon. Could send BLGO shares soaring.

$BLGO EPA Adds PFAS to CERCLA (Superfund) Law, Favoring Low-Waste Systems like BioLargo's AEC


https://www.accesswire.com/855647/epa-adds-pfas-to-cercla-superfund-law-favoring-low-waste-systems-like-biolargos-aec

BioLargo’s PFAS treatment technology generates a fraction of the waste compared to carbon filtration

WESTMINSTER, CA / ACCESSWIRE / April 23, 2024 / BioLargo, Inc. (OTCQB:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, today provided commentary on the importance of a final decision by the U.S. Environmental Protection Agency (EPA) to regulate two per- and polyfluoroalkyl substance (PFAS) chemicals as "hazardous substances" under the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA), also known as the Superfund law. BioLargo's PFAS treatment solution, the Aqueous Electrostatic Concentrator, generates a small fraction of the volume of PFAS-laden waste that carbon filtration systems generate, thus reducing operational costs of waste handling, transport, and disposal.

In the EPA press release, EPA Administrator Michael S. Regan stated, "Designating these chemicals under our Superfund authority will allow EPA to address more contaminated sites, take earlier action, and expedite cleanups, all while ensuring polluters pay for the costs to clean up pollution threatening the health of communities." These new regulations come on the heels of the EPA's announcement two weeks ago setting PFAS drinking water limits as low as four parts per trillion.

This new EPA action also means that these PFAS chemicals will be listed as "hazardous materials" under the Hazardous Materials Transportation Act, which will require materials containing these chemicals to be transported using special protocols.

Tonya Chandler, President of BioLargo Equipment Solutions & Technologies, Inc., which markets BioLargo's PFAS treatment systems, commented, "We believe these and other upcoming regulations create a price advantage for our AEC system over competing sorbent technologies such as carbon filtration. With less waste generated, we can also offer clients waste handling all the way through to full destruction at our facility."

These finalized CERCLA regulations are the most recent step by the EPA to limit exposure of Americans to PFAS. In addition to the recently announced federal drinking water standards for six PFAS chemicals, the agency also committed $9 billion in funding to help communities and water providers address contamination by PFAS and other emerging contaminants. This funding will assist communities and water providers to acquire PFAS monitoring and treatment systems to comply with new regulations.

Dennis P. Calvert, President and CEO of BioLargo, commented, "We're pleased to see the U.S. government taking PFAS seriously and dedicating the billions of dollars in funding needed to protect municipal water supplies across the country."

$BLGO BLGO COULD BE POSITIONED TO CAPTURE SUBSTANTIAL PORTION OF $9B GOVERNMENT PFAS SPENDING


https://richardacavalli.wixsite.com/greenplanetmicrocaps/why-blgo-shares-will-keep-rising

Looks like BLGO is going to go extremely BIG starting now! Big money expected to be moving into BLGO for many reasons. https://richardacavalli.wixsite.com/greenplanetmicrocaps/why-blgo-shares-will-keep-rising

$BLGO is only $.34/share and has breakthrough battery in beginning production now and several blockbuster products with very strong sales growth. Could be big 2024 winner.

My average basis is also just under .18, it feels good to finally breakout of the teens and move into the 30- 40 cent range. It would be nice to see it continue to climb. I am aware of all of those possibilities you listed, just wondering if it was more tied to one of them. It is great to have that cash flow from POOPH, to keep the dilution down.

Still running, does anyone have a guess as to why?
There are four big drivers emerging right now - Pooph revenues, Clyra marketing, PFAS remediation, and the battery rollout. Any one of them could be be causing the runup or, more likely, the collection of all this positive news has investors accumulating.

I have a clump of shares bought at 18 cents but regret not having the ability to purchase a bunch more at the time.

Still running, does anyone have a guess as to why?

Biolargo is really running today, I hope there is a good reason.

$BLGO https://nypost.com/2024/02/09/business/forever-chemicals-in-70m-american-water-systems-study/?utm_campaign=iphone_nyp&utm_source=mail_app

Only time will tell. I will believe the miracle battery when I see it producing revenue.

Nice to have the Pooph cash flow to limit dilution.

After years of consolidation BLGO is just starting breakout that could go from 24 cents to $3 really fast and much higher I. the next year. Going to be a monster company with revolutionary battery that runs circles around lithium ion. Also has the best water treatment solutions that are so good the CEO of the monster Southern California Municipal Water District and the previous Director of the EPA just joined the board of directors. This is the last pf the cheap stock under 30 cents. https://x.com/PENNYSTOCKKING7/status/1757151425719914688?s=20

Been waiting years for this to move and the time has come and we are just now starting a major move up that I believe is going to be epic and gigantic! POOPH sales are exploding, PFAS is a trillion dollar industry and BLGO has the unrivaled solution that is just starting to sell, Clyra has an FDA approved BioClynse that is about to become the new medical industry standard for disinfection, and BLGO is NOW starting production of the world's best battery that is a liquid sodium battery that does not catch fire or explode, it I cheap, uses no costly rare earths, can be rapid charged with no damage, lasts over 20 years, it is 4 times more powerful that lithium ion, can be recharged over 10,000 times (testing could show much more) . . .the battery alone is the kid of catalyst that could send BLGO shares to $10 overnight.

Been waiting years for this to move and the time has come and we are just now starting a major move up that I believe is going to be epic and gigantic! POOPH sales are exploding, PFAS is a trillion dollar industry and BLGO has the unrivaled solution that is just starting to sell, Clyra has an FDA approved BioClynse that is about to become the new medical industry standard for disinfection, and BLGO is NOW starting production of the world's best battery that is a liquid sodium battery that does not catch fire or explode, it I cheap, uses no costly rare earths, can be rapid charged with no damage, lasts over 20 years, it is 4 times more powerful that lithium ion, can be recharged over 10,000 times (testing could show much more) . . .the battery alone is the kid of catalyst that could send BLGO shares to $10 overnight.

hey got a first contract for PFAS
Look at it on: cleantech innovator Biolargo first there you can read: First PFAS REMOVAL CLIENT8

yes it is doubfulll. But going from the third semester , we receive 7.9 million and that is 107% higher than the semester before; i am in for the end of 2023 we go to 10million and perhaps more. I am waiting for the Aec when it receive the pro they need.

Biolargo cannot live by Pooph alone. It seems to be taking forever to get PFAS customers. Hopefully it will take off, the stock market appears to be doubtful.

results are coming, I hope very good!

There is hope, because of launching the water industry ,they have their first contract!

I just saw a commercial for Pooph on NFL Network, so I thought I would take a look on this board.

Revenue increase a lot and that is necessary! Because there are to much who blame the company in the past.

Nice to see revenue increasing!

No way with such results! they have for the first quarter 3.742.000 revenues against revenues last year were 1.544.000 that's more than 288% against last year? Wich company can give you this numbers????. Be in a hurry to buy now. The price is not what it means. This company will show you this year what it can do!!

I’m buying. If it goes below .17 I’ll set a stop loss but with upcoming catalyst, I’m a buyer at this price. Fwiw. Glta

I can't agree with you! The firm is in a better condition now. You can read it on Bezinga was speaking about the company and the start from now!

You are right Blgo was a disaster for years, but now I think they are on the good way and it is time to buy some shares. It is good to invest now because they have got + 130% over the last year and they say we will have the same for the year 1923! and think about it this year we will sure have + e/sh. . Can you imagine that ? After all this promesses I believe they cannot hold this price must be higher also with the water market too. The reason know is the waterindustry and of course Pooph it is really a tresor for them!

Been following BioLargo for a few years now. I don't own any of it. Yet. Things do seem to be moving along. But man alive the share structure of this company is a wreck. The whole reason for the share price and action to be essentially stuck in place for years is flat-out dilution of the common stock. And the company baldly states in the 10K that they fully plan on more dilution to fund operations in 2023.
Money is scarce for this company, as is the case for most all microcap startups, so I understand the difficulties of cash raises. But it is the common share that is bearing the weight of the load, and I don't see that changing until the share and cash-flow structure are significantly cleaned up. I guess I will keep watching from a distance.

All the best,
Silversmith

Read the 10K filed Friday. Check out the performance of BioLargo's new battery. (this could be trillion dollar asset). Look at POOPH sales racking up exponential growth. The huge Waste to Energy contracts will be shifting to the actual work and the number will be very big. And there are likely to be many more added. The Nuclear contacts are growing. Clyra sales are about to explode. PFAS sale are about to explode. Garrett Callahan sales are about explode. And don't forget about the AOS sales that are hitting about the same time as AEC.

Company is very close to break even and profitability will develop rapidly and very very big. Current share price is giveaway.
sec.gov/ix?doc=/Archives/ed...

Joe speaking on yahoo : Finally we know the real value of our shares, and at Monday we will hear more! 0.40$ is in the picture. Im also happy wiith the stories of Pooph! It is a way to invest
Thank you all for the support

The company have the money and now they can go higher , finally! You can invest here!